| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/08/2004 | EP1453916A2 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 09/08/2004 | EP1453829A1 Sulfonamido substituted imidazopyridines |
| 09/08/2004 | EP1453804A2 Ccr-3 receptor antagonists vii |
| 09/08/2004 | EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 09/08/2004 | EP1453796A2 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same |
| 09/08/2004 | EP1453795A2 Esters and amides as ppar-alpha agonists |
| 09/08/2004 | EP1453546A2 Treatment of angiogenesis disorders using targeted nanoparticles |
| 09/08/2004 | EP1453539A2 Immunotherapeutic methods and systems |
| 09/08/2004 | EP1453523A1 Heparin-containing ophthalmic agent |
| 09/08/2004 | EP1453514A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma |
| 09/08/2004 | EP1453503A2 Ep4 receptor agonist, compositions and methods thereof |
| 09/08/2004 | EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 09/08/2004 | EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/08/2004 | EP1089994B1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 09/08/2004 | CN1527838A Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 09/08/2004 | CN1527814A Nitric oxide synthase inhibitor phosphate salt |
| 09/08/2004 | CN1527719A Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 09/08/2004 | CN1527704A Compositions and method of administering tubulin binding agents for the treatment of ocular diseases |
| 09/08/2004 | CN1527689A Insert for the treatment of dry eye |
| 09/08/2004 | CN1526735A Immune globulin and its prepn and application |
| 09/08/2004 | CN1526408A Ribavirin gel as eye medicine and its production process |
| 09/08/2004 | CN1165522C Bradykinin receptor antagonists |
| 09/08/2004 | CN1165315C Remedies for joint diseases |
| 09/07/2004 | US6787554 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives |
| 09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/07/2004 | US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |
| 09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
| 09/07/2004 | US6787539 2,4,5,-trisubstituted pyrimidine derivatives |
| 09/07/2004 | US6787536 Hydroxamic acid derivatives |
| 09/07/2004 | US6787532 Formulation containing anti-inflammatory androstane derivatives |
| 09/07/2004 | US6787521 Skin disorders; kidney and liver disorders |
| 09/02/2004 | WO2004074240A1 Prostaglandin derivatives |
| 09/02/2004 | WO2004073748A1 Aqueous suspension medicine |
| 09/02/2004 | WO2004073722A1 Superoxide anion decomposing agent |
| 09/02/2004 | WO2004073711A2 Methods involving pde4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologies |
| 09/02/2004 | WO2004073701A1 Lfa-1 inhibitors and use thereof |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | WO2003084539A3 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 09/02/2004 | US20040171830 Carboline derivatives as pdev inhibitors |
| 09/02/2004 | US20040171802 Haemophilus influenzae antigens and corresponding dna fragments |
| 09/02/2004 | US20040171681 Medicines and medicinal kits |
| 09/02/2004 | US20040171676 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 09/02/2004 | US20040171628 Benzo [g] quinoline derivatives for treating glaucoma and myopia |
| 09/02/2004 | US20040171618 Compounds as PDE IV and TNF-inhibitors |
| 09/02/2004 | US20040171615 Substituted 1-aryl-but-3-enylamine and 1-aryl-but-2-enylamine compounds |
| 09/02/2004 | US20040171597 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 09/02/2004 | US20040171590 Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents |
| 09/02/2004 | US20040171581 Polysaccharidic esters of retinoic acid |
| 09/02/2004 | US20040171558 sulfamate; represented by topiramate; retinal embolism, ischemic optic neuropathy, macular degeneration, retinitis pigmentosa or Leber's disease |
| 09/02/2004 | US20040171549 Method of inhibiting angiogenesis or invasion or formation of metastases |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171012 Nucleic acid-associated proteins |
| 09/02/2004 | US20040170712 Applying a Jojoba oil extruded from Jojoba seeds |
| 09/02/2004 | US20040170711 Medical effect of Jojoba oil in the treatment of anal diseases |
| 09/02/2004 | US20040170710 Treating vaginal diseases by applying Jojoba oil extruded from Jojoba seeds |
| 09/02/2004 | US20040170690 Tablet comprising cetirizine and pseudoephedrine |
| 09/02/2004 | US20040170667 Agents for relieving eye controlling function error |
| 09/02/2004 | US20040170620 Selected antibody compositions for binding to aminophospholipids |
| 09/02/2004 | CA2518311A1 Superoxide anion scavenger |
| 09/02/2004 | CA2516266A1 Methods involving pde4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologies |
| 09/01/2004 | EP1452527A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 09/01/2004 | EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
| 09/01/2004 | EP1451211A2 Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease |
| 09/01/2004 | EP1451210A2 Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451209A2 Tetra-,penta-,hexa- and heptapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451190A1 Triazolo(4,3-a)pyrido(2,3-d)pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof |
| 09/01/2004 | EP1451187A1 Amide substituted imidazopyridines |
| 09/01/2004 | EP1451186A2 Urea substituted imidazopyridines |
| 09/01/2004 | EP1451184A1 Dimeric compounds and their use as anti-viral agents |
| 09/01/2004 | EP1451167A1 Phenylalkynes |
| 09/01/2004 | EP1451153A1 Nk1 antagonists |
| 09/01/2004 | EP1450820A2 Method for treating or preventing inflammatory diseases |
| 09/01/2004 | EP1450811A2 2-aryl pyrrolopyrimidines for a1 and a3 receptors |
| 09/01/2004 | EP1450803A1 New uses for anti-malarial therapeutic agents |
| 09/01/2004 | EP1450798A1 Use of an ascomycin for the treatment of blepharitis |
| 09/01/2004 | EP1450779A1 Method for treating autoimmune diseases |
| 09/01/2004 | EP1450777A1 Pharmaceutical composition containing chalcone or its derivatives for matrix metalloproteinase inhibitory activity |
| 09/01/2004 | EP1450769A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 09/01/2004 | EP1237889B1 Antibiotic sultam and sultone derived oxazolidinones |
| 09/01/2004 | EP1221443B1 Substituted imidazolidinone derivatives |
| 09/01/2004 | EP1127058B1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 09/01/2004 | EP0944621B1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
| 09/01/2004 | EP0923530B1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 09/01/2004 | CN1526023A Determination of risk factors for cataract by aldose reductase genotype |
| 09/01/2004 | CN1525969A Benzo [g] quinoline derivatives for treating glaucoma and myopia |
| 09/01/2004 | CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/01/2004 | CN1525954A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 09/01/2004 | CN1525871A Nasal delivery devices |
| 09/01/2004 | CN1525863A Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 09/01/2004 | CN1525861A Method for treating ocular hypertension and glaucoma |
| 09/01/2004 | CN1525854A Remedies for allergic eye diseases |
| 09/01/2004 | CN1525849A Olopatadine formulations for topical administration |
| 09/01/2004 | CN1524579A Composite viscoelastic preparation |
| 09/01/2004 | CN1524557A Ixeris sonchifolia pharmaceutical formulation and its preparation method |
| 09/01/2004 | CN1524539A Chinese medicine preparation for treating hemorrhage of the ocular fundus vitreous opacity |
| 09/01/2004 | CN1524448A Nutritious health-care food for protecting eyes and producing method therefor |
| 09/01/2004 | CN1164327C Use of endothelium chalone in preparation of eye medicament |
| 09/01/2004 | CN1164297C Use of kudzu root ,kudzu root flavone and puerarin for prevention and cure of osteoporosis |
| 09/01/2004 | CN1164271C Stable xylometazoline and oxymetazoline solution |
| 08/31/2004 | US6784205 Compounds that modulate the activity of PTP-1B and TC-PTP |